menuclose
Our story

It Started With Patients Who Gave Up.

In private practice, our founder watched allergic patients choose misery over twice-weekly shots.Antihistamines and decongestants masked symptoms and brought side effects. Allergy shots treated the cause, but they took a year to work and demanded office visits twice a week. Many patients simply stopped coming.Sublingual immunotherapy, drops of the same antigen taken under the tongue, was already common in Europe. He began prescribing it in 1985, one of the first physicians in the country to do so broadly.Patients took the drops daily at home, so results came faster and compliance held. In 1995 he started AllergyEasy to share the program with other doctors and their patients.
What makes us different

One Serum, Built For Real Life.

Comprehensive, not minimalMost programs treat a handful of local allergens. Ours covers the major pollens of the world plus molds, dust and dander, 60+ antigens in one mix.
Food allergies tooA separate food serum covers 59 food antigens. Few programs in the country actively treat food allergy.
Prescribed by your own doctorPrimary care physicians, pediatricians and specialists prescribe through our network, so you do not need an allergist referral.
Drops · Not Shots · Taken At Home
Why comprehensive

Allergy Tests Miss Things. The Serum Does Not.

Allergies change with age and geography, and skin tests return false negatives more often than people expect.A serum mixed only to a test result can miss the allergen doing the damage. Our comprehensive serum fills those gaps, so protection holds whether you travel, move or develop new sensitivities over time.That is also why some patients respond well on the drops after years of limited results on shots mixed to a narrow panel.
Questions

About AllergyEasy

Is AllergyEasy a clinic?No. AllergyEasy is a treatment program. Participating physicians test and prescribe, and a licensed compounding pharmacy prepares and ships your drops.
Where are you located?Our team serves patients and practices across the United States. Reach us at (480) 827-0038 or through the contact page.
How long have the drops been in use?Sublingual immunotherapy has been in popular use since the mid-1980s and accounts for a large share of allergy treatment in Europe. Our founder has prescribed it since 1985.
Ready To Be
DoneWith
Allergies?
Tell AllergyEasy about your allergies in a few minutes. We will tell you whether sublingual immunotherapy fits, and connect you with a prescribing provider near you.
Get Started
Are you a provider?Learn more →
The headline evidence

Reviewed, Recognized, Routine In Europe.

A Cochrane Collaboration review of 22 studies and 979 patients concluded sublingual immunotherapy is a safe treatment that reduces symptoms and medication needs in allergic rhinitis.The World Health Organization and the ARIA guidelines recognize sublingual immunotherapy as a safe, effective allergy treatment. European physicians have prescribed it for decades, and in France and Italy it is used more than shots.A 2007 update of the ARIA guidelines noted that the volume and quality of evidence for sublingual immunotherapy had come to match or exceed the evidence for injections.
Key findings

What The Studies Show.

Safety at homeCiprandi and Marseglia, 2011: sublingual immunotherapy carries a markedly lower risk of systemic reaction than injections, supporting home administration.
Safety under fiveRienzo and colleagues, 2005: a post-marketing survey found sublingual immunotherapy safe in children below age five.
Food allergyPublished trials have found sublingual immunotherapy safe and effective for milk, wheat, nut and other food allergies, where injections are not used.
Hundreds Of Published Studies And Growing
Our own numbers

What We See In Practice.

In our own program data, more than 80 percent of allergic patients and 90 percent of asthmatic patients reported marked relief within the first few months.Those are program observations rather than a controlled trial, and individual results vary. They are consistent with what the published literature reports for daily sublingual dosing: relief that begins within weeks and deepens over the first year.We recommend about three years of treatment for durable immune change. Some patients then stop without relapse; others keep a maintenance dose.
History

From Mercury To Immunotherapy.

Hay fever was described in 1819 by John Bostock, who tried opium, bleeding and mercury before noticing that staying indoors during the hay harvest helped.Charles Blackley identified pollen as the cause in the 1870s. In 1911 Leonard Noon and John Freeman injected pollen extracts in London and immunotherapy was born. Sublingual dosing emerged in the mid-1980s as the safer route and spread quickly through Europe.Our founder began prescribing it in 1985, among the first American physicians to do so at scale.